CIBC Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-137
Closed -$226K 1130
2019
Q2
$226K Hold
137
﹤0.01% 991
2019
Q1
$280K Buy
+137
New +$241K ﹤0.01% 864
2018
Q4
Sell
-137
Closed -$260K 1056
2018
Q3
$260K Hold
137
﹤0.01% 912
2018
Q2
$279K Buy
137
+30
+28% +$68.4K ﹤0.01% 860
2018
Q1
$236K Hold
107
﹤0.01% 901
2017
Q4
$247K Buy
+107
New +$217K ﹤0.01% 895

Other funds holding BLUE

CIBC Asset Management's BLUE Position: Q3 2019 in Review

CIBC Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 137 shares — an estimated $226K sold.

CIBC Asset Management first reported a position in BLUE in Q4 2017 and held it in 6 quarters. The position peaked at $280K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • CIBC Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • CIBC Asset Management sold 137 bluebird bio shares in Q3 2019, an estimated $226K.
  • CIBC Asset Management first reported a position in bluebird bio in Q4 2017 and held it in 6 quarters.
  • CIBC Asset Management's bluebird bio position peaked at $280K in Q1 2019.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on CIBC Asset Management's 13F filing for Q3 2019, filed 30 Oct 2019.